<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01674153</url>
  </required_header>
  <id_info>
    <org_study_id>DSRB - 2011/01942</org_study_id>
    <secondary_id>NKFRC/2011/01/06</secondary_id>
    <nct_id>NCT01674153</nct_id>
  </id_info>
  <brief_title>Investigating the Effects of Exercise on Physiological Changes and Toxin Removal in Hemodialysis Patients</brief_title>
  <official_title>A Multi Protocol Investigation to Compare the Effects of Intra-dialytic Exercise on Physiological Changes and Toxin Removal in Maintenance Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National University, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemodialysis is a life-saving treatment for end stage renal disease patients. The chief aims&#xD;
      of hemodialysis are solute and fluid removal. Solute removal is associated with outcome of&#xD;
      dialysis patients. Intra-dialytic exercise has been found to improve the toxin removal and it&#xD;
      is suggested that exercise increases the cardiac output, thus increases the blood flow to&#xD;
      lower extremities. This leads to increased toxin removal from low blood flow regions. On the&#xD;
      other hand, exercise can possibly dilate the vasculature and decrease the compartmental&#xD;
      resistance. In this study, the investigators aim to investigate the exercise induced&#xD;
      physiological changes which enhances the toxin removal. This information combined with&#xD;
      patient specific mathematical models will encourage clinicians to opt for Optimal&#xD;
      intra-dialytic exercise protocol. On the other hand, Hemodiafiltration is widely accepted&#xD;
      renal replacement therapy for improved toxin removal. Hence, we intend to compare the toxin&#xD;
      removal outcome for standalone Hemodiafiltration and intra-dialytic exercise in conventional&#xD;
      hemodialysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantify toxin removal</measure>
    <time_frame>6 months</time_frame>
    <description>Measure/estimate amount of toxin(s) removed and quantify corresponding physiological changes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare exercise regimen with HDF</measure>
    <time_frame>6 months</time_frame>
    <description>Compare amount of toxin removed for conventional hemodialysis (HD), HD with intra-dialytic exercise, and hemodiafiltration</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Renal Dialysis</condition>
  <arm_group>
    <arm_group_label>HD-Exercise-HDF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prescribe intra-dialytic exercise of three bouts in 4 hours dialysis session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra-dialytic exercise</intervention_name>
    <description>Perform intra-dialytic exercise of three bouts in 4 hours dialysis session. Each patient will perform exercise on Monark 881E rehab trainer (widely used in routine dialysis settings). The exercise intensity will be prescribed based on achievement of 50% of maximum heart rate for each recruited subject.</description>
    <arm_group_label>HD-Exercise-HDF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients male or female (Age &gt; 21 years)&#xD;
&#xD;
          -  Minimum dialysis vintage of 6 months&#xD;
&#xD;
          -  Stable on hemodialysis&#xD;
&#xD;
          -  Minimum Hemoglobin level of 10 g/dL&#xD;
&#xD;
          -  Blood access capable of delivering the blood flow rate greater than 250 mL/min&#xD;
&#xD;
          -  Preserved left ventricular ejection fraction (&gt;50%) on prior imaging study&#xD;
&#xD;
          -  Able to complete a 6min-walk-test without abnormal physiological response, excessive&#xD;
             fatigue, or musculoskeletal discomfort&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of recurring or persistent hypotension in past 3 months&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Severely Hypertensive patients (SBP &gt; 180 mmHg and/or DBP &gt; 115 mmHg)&#xD;
&#xD;
          -  History of recent myocardial infarction or unstable angina (within past 6 months)&#xD;
&#xD;
          -  Significant valvular disease, i.e. severe aortic stenosis and moderate-severe mitral&#xD;
             regurgitation.&#xD;
&#xD;
          -  Patients with end stage organ disease e.g. COPD, recent or debilitating CVA&#xD;
&#xD;
          -  Patient with recent stroke (within past 6 months)&#xD;
&#xD;
          -  Anemic patients&#xD;
&#xD;
          -  History of known arrhythmia&#xD;
&#xD;
          -  Participation in another clinical intervention trial&#xD;
&#xD;
          -  Moderate to severe osteoarthritis of knee(s)&#xD;
&#xD;
          -  Unable to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Titus Lau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Titus Lau, MD</last_name>
    <phone>+65 6772 4388</phone>
    <phone_ext>4388</phone_ext>
    <email>titus_lau@nuhs.edu.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vaibhav Maheshwari, B.Tech.</last_name>
    <phone>+65 9354 1493</phone>
    <email>vmaheshwari@nus.edu.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dialysis Center, National University of Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Titus Lau, MD</last_name>
      <phone>+65 6772 4388</phone>
      <email>titus_lau@nuhs.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Titus Lau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis. 2004 Jan;43(1):85-9.</citation>
    <PMID>14712431</PMID>
  </reference>
  <results_reference>
    <citation>Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int. 2006 Apr;69(8):1431-7.</citation>
    <PMID>16395268</PMID>
  </results_reference>
  <results_reference>
    <citation>Maheshwari V, Samavedham L, Rangaiah GP. A regional blood flow model for Î²2-microglobulin kinetics and for simulating intra-dialytic exercise effect. Ann Biomed Eng. 2011 Dec;39(12):2879-90. doi: 10.1007/s10439-011-0383-5. Epub 2011 Aug 30. Erratum in: Ann Biomed Eng. 2012 May;40(5):1205.</citation>
    <PMID>21877220</PMID>
  </results_reference>
  <results_reference>
    <citation>Parsons TL, Toffelmire EB, King-VanVlack CE. Exercise training during hemodialysis improves dialysis efficacy and physical performance. Arch Phys Med Rehabil. 2006 May;87(5):680-7.</citation>
    <PMID>16635631</PMID>
  </results_reference>
  <verification_date>April 2014</verification_date>
  <study_first_submitted>August 23, 2012</study_first_submitted>
  <study_first_submitted_qc>August 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2012</study_first_posted>
  <last_update_submitted>April 1, 2014</last_update_submitted>
  <last_update_submitted_qc>April 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intra-dialytic exercise</keyword>
  <keyword>Toxin removal</keyword>
  <keyword>Hemodiafiltration</keyword>
  <keyword>Inter-compartmental resistance</keyword>
  <keyword>Cardiac output</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

